| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 10/22/2002 | US6468741 Electrochemiluminescent rhenium moieties |
| 10/17/2002 | WO2002081472A1 Process for producing 2,6-dihalogenopurine |
| 10/17/2002 | WO2002080957A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 10/17/2002 | WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| 10/17/2002 | WO2001058241A9 Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 10/17/2002 | CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| 10/17/2002 | CA2440196A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 10/17/2002 | CA2410443A1 Process for producing 2,6-dihalogenopurine |
| 10/16/2002 | EP0948509B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 10/16/2002 | EP0759915B1 Asymmetric synthesis of chiral secondary alcohols |
| 10/16/2002 | CN1374967A Compounds for the treatment of ischemia |
| 10/16/2002 | CN1374962A 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 10/16/2002 | CN1374308A Antineoplastic active compound nitrene-phin and its prepn |
| 10/15/2002 | US6465650 Intermediate steps in preparing peptide nucleic acids |
| 10/10/2002 | WO2002079189A2 Spiroisoquinoline compounds, methods for their preparation and intermediates |
| 10/10/2002 | WO2002057287A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 10/10/2002 | US20020147174 Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy |
| 10/10/2002 | US20020147160 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/09/2002 | EP1246625A2 Methods and compositions for mitigating pain using nitrate esters |
| 10/09/2002 | CN1092193C Prolylendopeptidase inhibitors |
| 10/08/2002 | US6462044 Therapy for sexual disorders |
| 10/03/2002 | WO2002076460A2 Use of propentofylline to control intraocular pressure |
| 10/03/2002 | WO2002076404A2 Fatty alcohol drug conjugates |
| 10/03/2002 | WO2002076402A2 Fatty amine drug conjugates |
| 10/03/2002 | US20020143184 In crop protection and in the protection of materials |
| 10/03/2002 | US20020142000 Genetic engineering |
| 10/03/2002 | CA2434691A1 Use of propentofylline to control intraocular pressure |
| 10/02/2002 | EP1244668A1 Purine derivatives, process for their preparation and use thereof |
| 10/02/2002 | EP1244667A2 Cyclohexene nucleic acids |
| 10/02/2002 | EP1244666A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 10/02/2002 | EP1244658A2 Azolyl-alkyl azole derivatives, a method for their production and their use as pesticides |
| 10/02/2002 | EP0717750B1 Double-stranded peptide nucleic acids |
| 10/02/2002 | CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them |
| 10/01/2002 | US6458772 Prodrugs |
| 09/26/2002 | WO2002074780A1 Chemical compounds |
| 09/26/2002 | WO2002074753A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 09/26/2002 | WO2002030922A3 Dioxolane analogs for improved inter-cellular delivery |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/26/2002 | CA2441202A1 Chemical compounds |
| 09/26/2002 | CA2440405A1 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 09/25/2002 | EP1243593A2 Nucleotide analog composition and synthesis method |
| 09/25/2002 | EP1243590A2 Nucleotide analog composition and synthesis method |
| 09/25/2002 | EP1242427A1 Novel piperidine and piperazine derivatives |
| 09/25/2002 | EP1242153A1 Method and device for capturing fine particles by trapping in a solid mixture of carbon dioxide snow type |
| 09/25/2002 | CN1371376A Substituted purin derivatives as inhibitors of cell adhesion |
| 09/25/2002 | CN1091445C Intermediate of anti viral medicine, their preparation and use |
| 09/24/2002 | US6455696 Chlorination 2-amino-6-chloropyridine |
| 09/24/2002 | US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 09/24/2002 | US6455523 Inhibitors of farnesyl protein transferase |
| 09/24/2002 | CA2257807C Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity |
| 09/19/2002 | WO2002073208A2 Anti-epileptogenic agents |
| 09/19/2002 | WO2002072581A2 Pyrazolopyriadine derivatives |
| 09/19/2002 | US20020132830 Use of beta 2 bronchodilator drugs |
| 09/19/2002 | CA2440834A1 Anti-epileptogenic agents |
| 09/18/2002 | EP1241176A1 Purine derivatives for the treatment of ischemia |
| 09/18/2002 | EP1239883A2 Formulations of adenosine a1 agonists |
| 09/18/2002 | EP1239880A2 Formulations of adenosine a1 agonists |
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
| 09/18/2002 | CN1370170A DNA methyltransferase inhibitors |
| 09/17/2002 | US6452004 Useful as an intermediate of a carbocyclic nucleoside usefully used as an anti-viral agent |
| 09/17/2002 | US6451225 Mixtures of chelate compounds, amines and electrolytes used for chemical and quantitative analysis; detection of electromagnetic radiations emitted; accuracy |
| 09/17/2002 | CA2014662C Anti-virals |
| 09/16/2002 | CA2376738A1 Purine derivatives for the treatment of ischemia |
| 09/12/2002 | US20020128301 Non-nucleoside reverse transcriptase inhibitors |
| 09/12/2002 | US20020128278 Inhibit some of the ill effects caused by diabetes or by aging; preventing premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/12/2002 | US20020128195 Hydrophilic polymer covalently and reversibly linked to amine-containing ligand through dithiobenzyl linkage; improves blood circulation time |
| 09/11/2002 | EP1237890A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 09/10/2002 | US6448403 Dehalogenation and amination to synthesize such as 4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino)-2-cyclopentene-1 -methanol; chemical intermediates for purine nucleoside analogues |
| 09/10/2002 | US6448402 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol |
| 09/10/2002 | US6448400 Self-assembled ionophores |
| 09/10/2002 | US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease |
| 09/10/2002 | US6448261 Arylamino fused pyridines |
| 09/10/2002 | US6448256 Precursors of n-substituted derivatives of 6-aminouracils, 6-aminoisocytosines, guanines and 2-aminoadenines having a cleavable ester group; greater water solubility and oral bioavailability; treating gram positive bacterial infections |
| 09/10/2002 | US6448236 Functional agonists of the human adenosine a2a receptor and may be used as, for example, anti-inflammatory agents in the treatment of repiratory diseases |
| 09/06/2002 | WO2002068420A1 Xanthine derivative, production and use thereof as a medicament |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068409A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/06/2002 | WO2002008475A3 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/06/2002 | WO2001049687A9 Cyclohexene nucleic acids |
| 09/06/2002 | CA2438895A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/05/2002 | US20020123629 Benzothiadiazoles and derivatives |
| 09/05/2002 | US20020123501 Useful for premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/04/2002 | EP1235798A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | CN1367778A Novel carboxylic acid derivatives with 5,6 substitutedpyrimidine ring, their production and utilization thereof as endothelin receptor antagonists |
| 09/04/2002 | CN1367696A Method of enhancing insulin action |
| 09/03/2002 | US6444798 Genetic engineering |
| 09/03/2002 | CA2212052C N.alpha.-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066020A2 Modulation of gsk-3beta activity and its different uses |
| 08/29/2002 | US20020120130 Stereospecific preparation; use of 2',3' dideoxy-beta-L-fluorocytidine, as antiviral agent against HIV |
| 08/28/2002 | EP1234576A1 Us0027324for eating disorders |
| 08/28/2002 | EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/28/2002 | EP0882050B1 Process for preparing purine derivatives |
| 08/27/2002 | US6441018 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity |
| 08/27/2002 | US6440982 Inhibitors of cyclic guanosine monophosphate diesterases |
| 08/27/2002 | US6440979 Aryl isoguanines |
| 08/27/2002 | CA2062837C 8-substituted purines as selective adenosine receptor agents |
| 08/22/2002 | US20020115857 Useful as an intermediate of a carbocyclic nucleoside anti-viral agent; reacting 2-azabicyclo(2.2.1)hept-5-en-3-one with a sulfonyl halide or phosphoryl halide and then with a nucleic acid base |
| 08/22/2002 | US20020115671 Inhibitors of p38-a kinase |